Body's own cell-to-cell messaging packets studied as the basis for next-generation medicines

AI Summary

Researchers at the Blood and Tissue Bank on the Isle of Man are studying extracellular vesicles, nanoparticles released by cells that carry biological information, to develop next-generation medicines. These vesicles have important roles in tissue regeneration and inflammation modulation, potentially advancing therapies for diseases like cancer.

The Blood and Tissue Bank is studying how to therapeutically manufacture and use a type of nanoparticles released by the body's cells to communicate with one another, in one of the most promising fields of research for the therapies of the future. New medicines and advanced therapies modify cells (immune cells), genes and tissues to treat diseases such as cancer. However, the next step is to focus on these subcellular packages loaded with biological information, known as extracellular vesicles (EVs), which perform essential functions such as tissue regeneration and the modulation of inflammation.